title: Prognosis of lung cancer patients in Japan according to data from the Japanese Joint Committee of Lung Cancer Registry.
abstract: An organ-based lung cancer registry is currently maintained by the Japan Joint Committee of Lung Cancer Registry; this registry contributes to the development of lung cancer treatments and provides TNM classification data. In Japan, the overall 5-year survival rate has improved over time to 52% in 2004; the corresponding rates for each pathologic stage have also improved. Previously, separate registries were maintained for surgical and non-biased cases, whereas a prospective registry for non-surgical cases was added in 2012, and a follow-up examination of those data will be conducted in 2016. In addition, a registry of surgical cases from 2010 will be constructed in 2016. The information provided by these registries should better reveal the status of lung cancer patients in Japan.
authors.affiliation: General Thoracic Surgery, Hoshigaoka Medical Center, Japan Community Health Care Organization, 4-8-1 Hoshigaoka, Hirakata City, Osaka 573-8511, Japan; Osaka University Graduate School of Medicine, 2-7 Yamadaoka, Suita City, Osaka 565-0871, Japan. Electronic address: nsawabata@hoshigaoka-hp.com.
authors.forename: Noriyoshi
authors.initials: N
authors.lastname: Sawabata
mesh_terms: D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007564:Japan; D008175:Lung Neoplasms / Q000145:classification / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration*; D011379:Prognosis; D012042:Registries; D015996:Survival Rate; D013997:Time Factors
keywords: Japan; Lung cancer; Registry; Survival